Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
Article in Expert Review of Vaccines (September 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (September 2024)
Article in Frontiers in Immunology (November 2023)